FDA Panel Statements Prompt Pharmacies to Pull Popular Nasal Decongestants from Pharmacy Shelves
Conventional over-the-counter cold meds promise cold symptom relief right on the front of their packaging, but U.S. Food and Drug Administration (FDA) advisors have stated that an active ingredient in many popular cold medicines is not effective in relieving congestion when taken orally. An advisory panel for the FDA unanimously concluded recently that phenylephrine, a […]
Nearly 50 Percent of Federal Panelists Making Dietary Recommendations Have Money Ties to Food Industry
About half of the members of a U.S. federal government panel that shapes dietary recommendations in the United States have significant financial ties to big agriculture, processed food companies, weight loss companies, pharmaceutical companies, and other corporate organizations a recent report reveals. An additional four committee members had “possible” financial conflicts of interest.1 The Dietary […]
Blacklisting and Censorship Violates Freedom of Thought, Speech and Conscience | Barbara Loe Fisher
This is a commentary about a special report I have researched and written on the systematic shaming and blaming of parents with vaccine-injured children and the silencing of my voice and information published by the charitable National Vaccine Information Center in the digital public square—both before and after the declaration of a coronavirus pandemic in […]
How Did the Corruption of Public Health Happen?
International public health is a mess. Once seen generally as a public good, the focus of the World Health Organization (WHO) now more closely resembles a scheme for extracting private profit from the public purse. Wealthy corporations drive a ‘public-private partnership’ agenda, the foundations of the rich determine global priorities, and a propagandized public are […]
Study Finds Increased Risk of Stroke in Elderly After COVID and High Dose/Adjuvanted Influenza Shots
On Jan. 13 2023, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for U.S. Disease Control and Prevention (CDC)) issued a public statement regarding the identification of a preliminary safety signal for ischemic stroke among adults over the age of 65 that occurs between one to 21 days after receiving Pfizer/BioNTech’s monovalent […]
Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390. According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]
